{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:47:55Z","timestamp":1791344875590,"version":"4.3.1"},"reference-count":156,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"abstract":"<jats:p>Respiratory failure secondary to surfactant deficiency is a major cause of morbidity and mortality in preterm infants. Surfactant therapy substantially reduces mortality and respiratory morbidity for this population. Secondary surfactant deficiency also contributes to acute respiratory morbidity in late-preterm and term neonates with meconium aspiration syndrome, pneumonia\/sepsis, and perhaps pulmonary hemorrhage; surfactant replacement may be beneficial for these infants. This statement summarizes indications, administration, formulations, and outcomes for surfactant-replacement therapy. The impact of antenatal steroids and continuous positive airway pressure on outcomes and surfactant use in preterm infants is reviewed. Because respiratory insufficiency may be a component of multiorgan dysfunction, preterm and term infants receiving surfactant-replacement therapy should be managed in facilities with technical and clinical expertise to administer surfactant and provide multisystem support.<\/jats:p>","DOI":"10.1542\/peds.2007-3283","type":"journal-article","created":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T18:40:00Z","timestamp":1201891200000},"page":"419-432","source":"Crossref","is-referenced-by-count":225,"title":["Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate"],"prefix":"10.1542","volume":"121","author":[{"given":"William A.","family":"Engle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and the Committee on Fetus and Newborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,2,1]]},"reference":[{"key":"2021120820163982700_R1","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Fetus and Newborn. Surfactant replacement therapy for respiratory distress syndrome. Pediatrics.\u20081999;103(3):684\u2013685","DOI":"10.1542\/peds.103.3.684"},{"key":"2021120820163982700_R2","doi-asserted-by":"crossref","unstructured":"Soll RF. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev.\u20082000;2:CD001079","DOI":"10.1002\/14651858.CD000510"},{"key":"2021120820163982700_R3","doi-asserted-by":"crossref","unstructured":"Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev.\u20082000;2:CD000511","DOI":"10.1002\/14651858.CD000510"},{"key":"2021120820163982700_R4","unstructured":"Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev.\u20082000;2:CD001149"},{"key":"2021120820163982700_R5","doi-asserted-by":"crossref","unstructured":"Corbet A, Bucciarelli R, Goldman S, Mammel M, Wold D, Long W. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group I. J Pediatr.\u20081991;118(2):277\u2013284","DOI":"10.1016\/S0022-3476(05)80502-5"},{"key":"2021120820163982700_R6","doi-asserted-by":"crossref","unstructured":"Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics.\u20081985;76(2):145\u2013153","DOI":"10.1016\/0883-9441(87)90128-6"},{"key":"2021120820163982700_R7","doi-asserted-by":"crossref","unstructured":"Hoekstra RE, Jackson JC, Myers TF, et al. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics.\u20081991;88(1):10\u201318","DOI":"10.1542\/peds.88.1.10"},{"key":"2021120820163982700_R8","doi-asserted-by":"crossref","unstructured":"Liechty EA, Donovan E, Purohit D, et al. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics.\u20081991;88(1):19\u201328","DOI":"10.1542\/peds.88.1.19"},{"key":"2021120820163982700_R9","doi-asserted-by":"crossref","unstructured":"Long W, Corbet A, Cotton R, et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I and the Canadian Exosurf Neonatal Study Group. N Engl J Med.\u20081991;325(24):1696\u20131703","DOI":"10.1056\/NEJM199112123252404"},{"key":"2021120820163982700_R10","doi-asserted-by":"crossref","unstructured":"Shapiro DL, Notter RH, Morin FC III, et al. Double-blind randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Pediatrics.\u20081985;76(4):593\u2013599","DOI":"10.1542\/peds.76.4.593"},{"key":"2021120820163982700_R11","doi-asserted-by":"crossref","unstructured":"Soll RF, Hoekstra RE, Fangman JJ, et al. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Pediatrics.\u20081990;85(6):1092\u20131102","DOI":"10.1542\/peds.85.6.1092"},{"key":"2021120820163982700_R12","doi-asserted-by":"crossref","unstructured":"Lang MJ, Hall RT, Reddy NS, Kurth CG, Merritt TA. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants. J Pediatr.\u20081990;116(6):295\u2013300","DOI":"10.1016\/S0022-3476(05)82897-5"},{"key":"2021120820163982700_R13","unstructured":"Kresch MJ, Clive JM. Meta-analyses of surfactant replacement therapy of infants with birth weights less than 2000 grams. J Perinatol.\u20081998;18(4):276\u2013283"},{"key":"2021120820163982700_R14","doi-asserted-by":"crossref","unstructured":"Collaborative European Multicenter Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics.\u20081988;82(5):683\u2013691","DOI":"10.1542\/peds.82.5.683"},{"key":"2021120820163982700_R15","doi-asserted-by":"crossref","unstructured":"Horbar JD, Wright EC, Onstad L. Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. The Members of the National Institute of Child Health and Human Development Neonatal Research Network. Pediatrics.\u20081993;92(5):191\u2013196","DOI":"10.1097\/00006254-199403000-00012"},{"key":"2021120820163982700_R16","doi-asserted-by":"crossref","unstructured":"Ten Centre Study Group. Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Br Med J (Clin Res Ed).\u20081987;294(6578):991\u2013996","DOI":"10.1136\/bmj.294.6578.991"},{"key":"2021120820163982700_R17","doi-asserted-by":"crossref","unstructured":"Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med.\u20081994;330(21):1476\u20131480","DOI":"10.1056\/NEJM199405263302102"},{"key":"2021120820163982700_R18","doi-asserted-by":"crossref","unstructured":"Horbar JD, Badger GJ, Carpenter JH, et al. Trends in mortality and morbidity for very low birth weight infants, 1991\u20131999. Pediatrics.\u20082002;110(1 pt 1):143\u2013151","DOI":"10.1542\/peds.110.1.143"},{"key":"2021120820163982700_R19","doi-asserted-by":"crossref","unstructured":"St John EB, Carlo WA. Respiratory distress syndrome in VLBW infants: changes in management and outcomes observed by the NICHD Neonatal Research Network. Semin Perinatol.\u20082003;27(4):288\u2013292","DOI":"10.1016\/S0146-0005(03)00056-9"},{"key":"2021120820163982700_R20","doi-asserted-by":"crossref","unstructured":"Morley CJ. Systematic review of prophylactic vs rescue surfactant. Arch Dis Child Fetal Neonatal Ed.\u20081997;77(1):F70\u2013F74","DOI":"10.1136\/fn.77.1.F70"},{"key":"2021120820163982700_R21","doi-asserted-by":"crossref","unstructured":"Kwong MS, Egan EA, Notter RH, Shapiro DL. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics.\u20081985;76(4):585\u2013592","DOI":"10.1542\/peds.76.4.585"},{"key":"2021120820163982700_R22","unstructured":"Kattwinkel J, Bloom BT, Delmore P. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics.\u20081993;92(1):90\u201398"},{"key":"2021120820163982700_R23","doi-asserted-by":"crossref","unstructured":"Kendig JW, Notter RH, Cox C, et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. N Engl J Med.\u20081991;324(13):865\u2013871","DOI":"10.1056\/NEJM199103283241301"},{"key":"2021120820163982700_R24","doi-asserted-by":"crossref","unstructured":"Merritt TA, Hallman M, Berry C, et al. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J Pediatr.\u20081991;118(4 pt 1):581\u2013594","DOI":"10.1016\/S0022-3476(05)83387-6"},{"key":"2021120820163982700_R25","doi-asserted-by":"crossref","unstructured":"Egberts J, Brand R, Walti H, Bevilacqua G, Bre\u0301art G, Gardini F. Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf. Pediatrics.\u20081997;100(1). Available at: www.pediatrics.org\/cgi\/content\/full\/100\/1\/e4","DOI":"10.1542\/peds.100.1.e4"},{"key":"2021120820163982700_R26","doi-asserted-by":"crossref","unstructured":"Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev.\u20082001;2:CD000510","DOI":"10.1002\/14651858.CD000510"},{"key":"2021120820163982700_R27","doi-asserted-by":"crossref","unstructured":"Egberts J, de Winter JP, Sedin G, et al. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Pediatrics.\u20081993;92(6):768\u2013774","DOI":"10.1542\/peds.92.6.768"},{"key":"2021120820163982700_R28","doi-asserted-by":"crossref","unstructured":"Bevilacqua G, Parmigiani S, Robertson B. Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial. J Perinat Med.\u20081996;24(6):609\u2013620","DOI":"10.1515\/jpme.1996.24.6.609"},{"key":"2021120820163982700_R29","doi-asserted-by":"crossref","unstructured":"Dunn MS, Shennan AT, Zayack D, Possmayer F. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Pediatrics.\u20081991;87(3):377\u2013386","DOI":"10.1542\/peds.87.3.377"},{"key":"2021120820163982700_R30","doi-asserted-by":"crossref","unstructured":"Walti H, Paris-Llado J, Bre\u0301art G, Couchard M. Porcine surfactant replacement therapy in newborns of 25\u201331 weeks' gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low doses. The French Collaborative Multicentre Study Group. Acta Paediatr.\u20081995;84(8):913\u2013921","DOI":"10.1111\/j.1651-2227.1995.tb13792.x"},{"key":"2021120820163982700_R31","doi-asserted-by":"crossref","unstructured":"Horbar JD, Carpenter JH, Buzas J, et al. Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: is routine practice evidence based?Pediatrics.\u20082004;113(3):1593\u20131602","DOI":"10.1542\/peds.113.6.1593"},{"key":"2021120820163982700_R32","doi-asserted-by":"crossref","unstructured":"Horbar JD, Carpenter JH, Buzas J, et al. Collaborative quality improvement to provide evidence based surfactant for preterm infants: a cluster randomized trial. BMJ.\u20082004;329(7473):1004","DOI":"10.1136\/bmj.329.7473.1004"},{"key":"2021120820163982700_R33","doi-asserted-by":"crossref","unstructured":"Walti H, Paris-Llado J, Egberts J, et al. Prophylactic administration of porcine-derived lung surfactant is a significant factor in reducing the odds for peri-intraventricular haemorrhage in premature infants. Biol Neonate.\u20082002;81(3):182\u2013187","DOI":"10.1159\/000051532"},{"key":"2021120820163982700_R34","doi-asserted-by":"crossref","unstructured":"Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev.\u20082000;2:CD001456","DOI":"10.1002\/14651858.CD001456"},{"key":"2021120820163982700_R35","doi-asserted-by":"crossref","unstructured":"Gortner L, Wauer RR, Hammer H, et al. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial. Pediatrics.\u20081998;102(5):1153\u20131160","DOI":"10.1542\/peds.102.5.1153"},{"key":"2021120820163982700_R36","doi-asserted-by":"crossref","unstructured":"Escobedo MB, Gunkel JH, Kennedy KA, et al. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr.\u20082004;144(6):804\u2013808","DOI":"10.1016\/j.jpeds.2004.03.024"},{"key":"2021120820163982700_R37","unstructured":"Vermont-Oxford Neonatal Network. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics.\u20081996;97(1):1\u20136"},{"key":"2021120820163982700_R38","doi-asserted-by":"crossref","unstructured":"Ainsworth SB, Beresford MW, Milligan DWA. Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25\u201329 weeks' gestation: a randomized trial. Lancet.\u20082000;355(9213):1387\u20131392","DOI":"10.1016\/S0140-6736(00)02136-X"},{"key":"2021120820163982700_R39","doi-asserted-by":"crossref","unstructured":"Sinha S, Lacaze-Masmoneil T, Valis i Soler A, et al. A randomized, controlled trial of lucinactant versus poractant alfa in very premature infants at high risk for respiratory distress syndrome. Pediatrics.\u20082005;115(4):1030\u20131038","DOI":"10.1542\/peds.2004-2231"},{"key":"2021120820163982700_R40","doi-asserted-by":"crossref","unstructured":"Moya F, Gadzinowski J, Bancalari E, et al. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome in very preterm infants. Pediatrics.\u20082005;115(4):1018\u20131029","DOI":"10.1542\/peds.2004-2183"},{"key":"2021120820163982700_R41","doi-asserted-by":"crossref","unstructured":"Kattwinkel J. Synthetic surfactants: the search goes on. Pediatrics.\u20082005;115(4):1075\u20131076","DOI":"10.1542\/peds.2005-0202"},{"key":"2021120820163982700_R42","doi-asserted-by":"crossref","unstructured":"Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol.\u20082004;21(3):109\u2013119","DOI":"10.1055\/s-2004-823779"},{"key":"2021120820163982700_R43","doi-asserted-by":"crossref","unstructured":"Clark RH, Auten RL, Peabody J. A comparison of the outcomes of neonates treated with two different natural surfactants. J Pediatr.\u20082001;139(6):828\u2013831","DOI":"10.1067\/mpd.2001.119624"},{"key":"2021120820163982700_R44","doi-asserted-by":"crossref","unstructured":"Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev.\u20082000;2:CD000144","DOI":"10.1002\/14651858.CD000144"},{"key":"2021120820163982700_R45","doi-asserted-by":"crossref","unstructured":"Halliday HL. History of surfactant from 1980. Biol Neonate.\u20082005;87(4):317\u2013322","DOI":"10.1159\/000084879"},{"key":"2021120820163982700_R46","doi-asserted-by":"crossref","unstructured":"Hudak ML, Martin DJ, Egan EA, et al. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. Pediatrics.\u20081997;100(1):39\u201350","DOI":"10.1542\/peds.100.1.39"},{"key":"2021120820163982700_R47","doi-asserted-by":"crossref","unstructured":"Horbar JD, Wright LL, Soll RF, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr.\u20081993;123(5):757\u2013766","DOI":"10.1016\/S0022-3476(05)80856-X"},{"key":"2021120820163982700_R48","doi-asserted-by":"crossref","unstructured":"Bloom BT, Kattwinkel J, Hall RT, et al. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics.\u20081997;100(1):31\u201338","DOI":"10.1542\/peds.100.1.31"},{"key":"2021120820163982700_R49","doi-asserted-by":"crossref","unstructured":"Cochrane CG, Revak SD, Merritt TA, et al. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome. Am J Respir Crit Care Med.\u20081996;153(1):404\u2013410","DOI":"10.1164\/ajrccm.153.1.8542150"},{"key":"2021120820163982700_R50","doi-asserted-by":"crossref","unstructured":"Davis AJ, Jobe AH, Hafner D, Ikegami M. Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant. Am J Respir Crit Care Med.\u20081998;157(2):553\u2013559","DOI":"10.1164\/ajrccm.157.2.97-08019"},{"key":"2021120820163982700_R51","doi-asserted-by":"crossref","unstructured":"Pfister RH, Soll RF. New synthetic surfactants: the next generation?Biol Neonate.\u20082005;87(4):338\u2013344","DOI":"10.1159\/000084882"},{"key":"2021120820163982700_R52","doi-asserted-by":"crossref","unstructured":"Chida S, Phelps DS, Soll RF, Taeusch HW. Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment. Pediatrics.\u20081991;88(1):84\u201389","DOI":"10.1542\/peds.88.1.84"},{"key":"2021120820163982700_R53","doi-asserted-by":"crossref","unstructured":"Whitsett JA, Hull WM, Luse S. Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with Survanta, a modified bovine surfactant. Pediatrics.\u20081991;87(1):505\u2013510","DOI":"10.1542\/peds.87.4.505"},{"key":"2021120820163982700_R54","doi-asserted-by":"crossref","unstructured":"Moya F, Sinha S, Gadzinowski J, et al. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials [published correction appears in Pediatrics. 2007;120(4):935]. Pediatrics.\u20082007;119(6). Available at: www.pediatrics.org\/cgi\/content\/full\/119\/6\/e1361","DOI":"10.1542\/peds.2006-0149"},{"key":"2021120820163982700_R55","doi-asserted-by":"crossref","unstructured":"Dunn MS, Shennan AT, Possmayer F. Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome. Pediatrics.\u20081990;86(4):564\u2013571","DOI":"10.1542\/peds.86.4.564"},{"key":"2021120820163982700_R56","doi-asserted-by":"crossref","unstructured":"Konishi M, Fujiwara T, Naito T, et al. Surfactant replacement therapy in neonatal respiratory distress syndrome: a multi-centre, randomized clinical trial\u2014comparison of high-versus low-dose of surfactant TA. Eur J Pediatr.\u20081988;147(1):20\u201325","DOI":"10.1007\/BF00442605"},{"key":"2021120820163982700_R57","doi-asserted-by":"crossref","unstructured":"Corbet A, Gerdes J, Long W, et al. Double blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa. J Pediatr.\u20081995;126(6):969\u2013978","DOI":"10.1016\/S0022-3476(95)70226-1"},{"key":"2021120820163982700_R58","doi-asserted-by":"crossref","unstructured":"Baroutis G, Kayleyias J, Liarou T, Papathoma E, Hatzistamatiou Z, Costalos C. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr.\u20082003;162(7\u20138):476\u2013480","DOI":"10.1007\/s00431-002-1144-0"},{"key":"2021120820163982700_R59","doi-asserted-by":"crossref","unstructured":"Kattwinkel J, Robinson M, Bloom BT, Delmore P, Ferguson JE. Technique for intrapartum administration of surfactant without requirement for endotracheal tube. J Perinatol.\u20082004;24(6):360\u2013365","DOI":"10.1038\/sj.jp.7211103"},{"key":"2021120820163982700_R60","doi-asserted-by":"crossref","unstructured":"Ueda T, Ikegami M, Rider ED, Jobe AH. Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol.\u20081994;76(1):45\u201355","DOI":"10.1152\/jappl.1994.76.1.45"},{"key":"2021120820163982700_R61","doi-asserted-by":"crossref","unstructured":"Zola EM, Gunkel JH, Chan RK, et al. Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome. J Pediatr.\u20081993;122(3):453\u2013459","DOI":"10.1016\/S0022-3476(05)83440-7"},{"key":"2021120820163982700_R62","doi-asserted-by":"crossref","unstructured":"Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med.\u20081996;334(22):1417\u20131421","DOI":"10.1056\/NEJM199605303342201"},{"key":"2021120820163982700_R63","doi-asserted-by":"crossref","unstructured":"Smedsaas-Lo\u0308fvenberg A, Nilsson K, Moa G, Axelsson I. Nebulization of drugs in a nasal CPAP system. Acta Paediatr.\u20081999;88(1):89\u201392","DOI":"10.1111\/j.1651-2227.1999.tb01275.x"},{"key":"2021120820163982700_R64","doi-asserted-by":"crossref","unstructured":"Berggren E, Liljedahl M, Winbladh B, et al. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr.\u20082000;89(4):460\u2013464","DOI":"10.1111\/j.1651-2227.2000.tb00084.x"},{"key":"2021120820163982700_R65","doi-asserted-by":"crossref","unstructured":"Kendig JW, Ryan RM, Sinkin RA, et al. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial. Pediatrics.\u20081998;101(6):1006\u20131012","DOI":"10.1542\/peds.101.6.1006"},{"key":"2021120820163982700_R66","doi-asserted-by":"crossref","unstructured":"Finer NN. Surfactant use for neonatal lung injury: beyond respiratory distress syndrome. Paediatr Respir Rev.\u20082004;5(suppl A):S289\u2013S297","DOI":"10.1016\/S1526-0542(04)90053-X"},{"key":"2021120820163982700_R67","doi-asserted-by":"crossref","unstructured":"Soll RF, Dargaville P. Surfactant for meconium aspiration syndrome in full term infants. Cochrane Database Syst Rev.\u20082000;2:CD002054","DOI":"10.1002\/14651858.CD002054"},{"key":"2021120820163982700_R68","doi-asserted-by":"crossref","unstructured":"Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics.\u20081996;97(1):48\u201352","DOI":"10.1542\/peds.97.1.48"},{"key":"2021120820163982700_R69","doi-asserted-by":"crossref","unstructured":"Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr.\u20081998;132(1):40\u201347","DOI":"10.1016\/S0022-3476(98)70482-2"},{"key":"2021120820163982700_R70","doi-asserted-by":"crossref","unstructured":"Khammash H, Perlman M, Wojtulewicz J, Donn M. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics.\u20081993;92(1):135\u2013139","DOI":"10.1542\/peds.92.1.135"},{"key":"2021120820163982700_R71","doi-asserted-by":"crossref","unstructured":"Herting E, Gefeller O, Land M, van Sonderen L, Harms K, Robertson B. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group. Pediatrics.\u20082000;106(5):957\u2013964; discussion 1135","DOI":"10.1542\/peds.106.5.957"},{"key":"2021120820163982700_R72","doi-asserted-by":"crossref","unstructured":"Wiswell TE, Knight GR, Finer NN, et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics.\u20082002;109(6):1081\u20131087","DOI":"10.1542\/peds.109.6.1081"},{"key":"2021120820163982700_R73","doi-asserted-by":"crossref","unstructured":"Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics.\u20081991;87(1):101\u2013107","DOI":"10.1542\/peds.87.1.101"},{"key":"2021120820163982700_R74","doi-asserted-by":"crossref","unstructured":"Lotze A, Knight GR, Martin GR, et al. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr.\u20081993;122(2):261\u2013268","DOI":"10.1016\/S0022-3476(06)80131-9"},{"key":"2021120820163982700_R75","doi-asserted-by":"crossref","unstructured":"Chinese Collaborative Study Group for Neonatal Respiratory Distress. Treatment of severe meconium aspiration syndrome with porcine surfactant: a multicenter, randomized, controlled trial. Acta Paediatr.\u20082005;94(7):896\u2013902","DOI":"10.1111\/j.1651-2227.2005.tb02008.x"},{"key":"2021120820163982700_R76","doi-asserted-by":"crossref","unstructured":"Fetter WP, Baerts W, Bos AP, van Lingen RA. Surfactant replacement therapy in neonates with respiratory failure due to bacterial sepsis. Acta Paediatr.\u20081995;84(1):14\u201316","DOI":"10.1111\/j.1651-2227.1995.tb13476.x"},{"key":"2021120820163982700_R77","doi-asserted-by":"crossref","unstructured":"Hintz SR, Suttner DM, Sheehan AM, Rhine WD, Van Meurs KP. Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Pediatrics.\u20082000;106(1):1339\u20131343","DOI":"10.1542\/peds.106.6.1339"},{"key":"2021120820163982700_R78","doi-asserted-by":"crossref","unstructured":"Dargaville PA, Mills JF, Soll RF. Therapeutic lung lavage for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev.\u20082002;1:CD003486","DOI":"10.1002\/14651858.CD003486"},{"key":"2021120820163982700_R79","doi-asserted-by":"crossref","unstructured":"Pandit PB, Dunn MS, Colucci EA. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics.\u20081995;95(1):32\u201336","DOI":"10.1542\/peds.95.1.32"},{"key":"2021120820163982700_R80","doi-asserted-by":"crossref","unstructured":"Amizuka T, Shimizu H, Niida Y, Gawa Y. Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema. Eur J Pediatr.\u20082003;162(10):697\u2013702","DOI":"10.1007\/s00431-003-1276-x"},{"key":"2021120820163982700_R81","doi-asserted-by":"crossref","unstructured":"Auten RL, Merzbach J, Myers G, Goldstein RF, Palumbo D. Neurodevelopmental and health outcomes in term infants treated with surfactant for severe respiratory failure. J Perinatol.\u20082000;20(5):291\u2013294","DOI":"10.1038\/sj.jp.7200375"},{"key":"2021120820163982700_R82","doi-asserted-by":"crossref","unstructured":"Cogo PE, Zimmermann LJ, Verlato G, et al. A dual stable isotope tracer method for the measurement of surfactant disaturated-phosphatidylcholine synthesis in infants with congenital diaphragmatic hernia. Pediatr Res.\u20082004;56(2):184\u2013190","DOI":"10.1203\/01.PDR.0000132665.73234.F6"},{"key":"2021120820163982700_R83","doi-asserted-by":"crossref","unstructured":"Cogo PE, Zimmerman LD, Meneghini L, et al. Pulmonary surfactant disaturated-phosphatidlycholine (DSPC) turnover and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res.\u20082003;54(5):653\u2013658","DOI":"10.1203\/01.PDR.0000084344.42409.C6"},{"key":"2021120820163982700_R84","doi-asserted-by":"crossref","unstructured":"Van Meurs K; Congenital Diaphragmatic Hernia Study Group. Is surfactant therapy beneficial in the treatment of the term newborn infant with congenital diaphragmatic hernia?J Pediatr.\u20082004;145(3):312\u2013316","DOI":"10.1016\/j.jpeds.2004.04.056"},{"key":"2021120820163982700_R85","doi-asserted-by":"crossref","unstructured":"Lally KP, Lally PA, Langham MR, et al. Surfactant does not improve survival rate in preterm infants with congenital diaphragmatic hernia. J Pediatr Surg.\u20082004;39(6):829\u2013833","DOI":"10.1016\/j.jpedsurg.2004.02.011"},{"key":"2021120820163982700_R86","doi-asserted-by":"crossref","unstructured":"Rivera S, Gaugler C, Langlet C, et al. Secondary surfactant deficiencies in extremely low birth weight premature infants [in French.]. Arch Pediatr.\u20082004;11(11):1346\u20131350","DOI":"10.1016\/S0929-693X(04)00459-2"},{"key":"2021120820163982700_R87","doi-asserted-by":"crossref","unstructured":"Escande B, Kuhn P, Rivera S, Messer J. Secondary surfactant deficiencies [in French]. Arch Pediatr.\u20082004;11(11):1351\u20131359","DOI":"10.1016\/j.arcped.2004.05.021"},{"key":"2021120820163982700_R88","doi-asserted-by":"crossref","unstructured":"Survanta Multidose Study Group. Two-year follow-up of infants treated for neonatal respiratory distress syndrome with bovine surfactant. Survanta Multidose Study Group. J Pediatr.\u20081994;124(6):962\u2013967","DOI":"10.1016\/S0022-3476(05)83193-2"},{"key":"2021120820163982700_R89","doi-asserted-by":"crossref","unstructured":"Corbet A, Long W, Schumacher R, Gerdes J, Cotton R. Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500\u20131350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactant. American Exosurf Neonatal Study Group I. J Pediatr.\u20081995;126(5 pt 2):S5\u2013S12","DOI":"10.1016\/S0022-3476(95)70002-1"},{"key":"2021120820163982700_R90","doi-asserted-by":"crossref","unstructured":"Pelkonen AS, Hakulinen AL, Turpeinen M, Hallman M. Effect of neonatal surfactant therapy on lung function at school age in children born very preterm. Pediatr Pulmonol.\u20081998;25(3):182\u2013190","DOI":"10.1002\/(SICI)1099-0496(199803)25:3<182::AID-PPUL8>3.0.CO;2-O"},{"key":"2021120820163982700_R91","doi-asserted-by":"crossref","unstructured":"Greenough A, Alexander J, Burgess S, et al. Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease. Arch Dis Child.\u20082002;86(1):40\u201343","DOI":"10.1136\/adc.86.1.40"},{"key":"2021120820163982700_R92","doi-asserted-by":"crossref","unstructured":"Dunn MS, Shennan AT, Hoskins EM, Enhorning G. Two-year follow-up of infants enrolled in a randomized trial of surfactant replacement therapy for prevention of neonatal respiratory distress syndrome. Pediatrics.\u20081988;82(4):543\u2013547","DOI":"10.1542\/peds.82.4.543"},{"key":"2021120820163982700_R93","doi-asserted-by":"crossref","unstructured":"Vaucher YE, Merritt TA, Hallman M, Jarvenpaa AL, Telsey AM, Jones BL. Neurodevelopmental and respiratory outcome in early childhood after human surfactant treatment. Am J Dis Child.\u20081988;142(9):927\u2013930","DOI":"10.1001\/archpedi.1988.02150090025015"},{"key":"2021120820163982700_R94","doi-asserted-by":"crossref","unstructured":"Abbasi S, Bhutani VK, Gerdes JS. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants with exogenous surfactant. J Pediatr.\u20081993;122(3):446\u2013452","DOI":"10.1016\/S0022-3476(05)83439-0"},{"key":"2021120820163982700_R95","doi-asserted-by":"crossref","unstructured":"Kraybill EN, Bose CL, Corbet AJ, et al. Double-blind evaluation of developmental and health status to age 2 years of infants weighing 700 to 1350 grams treated prophylactically at birth with a single dose of synthetic surfactant or air placebo. J Pediatr.\u20081995;126(5 pt 2):S33\u2013S42","DOI":"10.1016\/S0022-3476(95)70006-4"},{"key":"2021120820163982700_R96","doi-asserted-by":"crossref","unstructured":"Gaillard EA, Cooke RWI, Shaw NJ. Improved survival and neurodevelopmental outcome after prolonged ventilation in preterm neonates who have received antenatal steroids and surfactant. Arch Dis Child Fetal Neonatal Ed.\u20082001;84(3):F194\u2013F196","DOI":"10.1136\/fn.84.3.F194"},{"key":"2021120820163982700_R97","doi-asserted-by":"crossref","unstructured":"Casiro O, Bingham W, MacMurray B, et al. One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Follow-up Group. J Pediatr.\u20081995;126(5 pt 2):S53\u2013S60","DOI":"10.1016\/S0022-3476(95)70008-0"},{"key":"2021120820163982700_R98","doi-asserted-by":"crossref","unstructured":"Robertson B, Curstedt T, Tubman R, et al. A 2-year follow-up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group. Eur J Pediatr.\u20081992;151(5):372\u2013376","DOI":"10.1007\/BF02113261"},{"key":"2021120820163982700_R99","doi-asserted-by":"crossref","unstructured":"Couser RJ, Ferrara TB, Wheeler W, et al. Pulmonary follow-up 2.5 years after a randomized, controlled, multiple dose bovine study of preterm newborn infants. Pediatr Pulmonol.\u20081993;15(3):163\u2013167","DOI":"10.1002\/ppul.1950150307"},{"key":"2021120820163982700_R100","doi-asserted-by":"crossref","unstructured":"Hack M, Wilson-Costello D, Friedman H, Taylor GH, Schluchter M, Fanaroff AA. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992\u20131995. Arch Pediatr Adolesc Med.\u20082000;154(7):725\u2013731","DOI":"10.1001\/archpedi.154.7.725"},{"key":"2021120820163982700_R101","unstructured":"Palta M, Sadek-Badawi M, Evans M, Weinstein MR, McGuinness G. Functional assessment of a multicenter very low-birth-weight cohort at age 5 years. Newborn Lung Project. Arch Pediatr Adolesc Med.\u20082000;154(1):23\u201330"},{"key":"2021120820163982700_R102","doi-asserted-by":"crossref","unstructured":"D'Angio CT, Sinkin RA, Stevens TP, et al. Longitudinal, 15-year follow-up of children born at less than 29 weeks' gestation after introduction of surfactant therapy into a region: neurologic, cognitive, and educational outcomes. Pediatrics.\u20082002;110(6):1094\u20131102","DOI":"10.1542\/peds.110.6.1094"},{"key":"2021120820163982700_R103","doi-asserted-by":"crossref","unstructured":"Piecuch RE, Leonard CH, Cooper BA, Sehring SA. Outcome of extremely low birth weight infants (500 to 999 grams) over a 12-year period. Pediatrics.\u20081997;100(4):633\u2013639","DOI":"10.1542\/peds.100.4.633"},{"key":"2021120820163982700_R104","doi-asserted-by":"crossref","unstructured":"Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993\u20131994. Pediatrics.\u20082000;105(6):1216\u20131226","DOI":"10.1542\/peds.105.6.1216"},{"key":"2021120820163982700_R105","doi-asserted-by":"crossref","unstructured":"Stoelhorst GMSJ, Martens SE, Rijken M, et al. Behaviour at 2 years of age in very preterm infants (gestational age &lt;32 weeks). Acta Paediatr.\u20082003;92(5):595\u2013601","DOI":"10.1111\/j.1651-2227.2003.tb02513.x"},{"key":"2021120820163982700_R106","doi-asserted-by":"crossref","unstructured":"Bo\u0308hm B, Katz-Salamon M. Cognitive development at 5.5 years of children with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed.\u20082003;88(2):F101\u2013F105","DOI":"10.1136\/fn.88.2.F101"},{"key":"2021120820163982700_R107","doi-asserted-by":"crossref","unstructured":"Hoekstra RE, Ferrara TB, Couser RJ, Payne NR, Connett JE. Survival and long-term neurodevelopmental outcome of extremely premature infants born at 23\u201326 weeks' gestational age at tertiary center. Pediatrics.\u20082004;113(1). Available at: www.pediatrics.org\/cgi\/content\/full\/113\/1\/e1","DOI":"10.1542\/peds.113.1.e1"},{"key":"2021120820163982700_R108","doi-asserted-by":"crossref","unstructured":"Saigal S, Stoskopf BL, Streiner DL, et al. Physical growth and current health status of infants who were of extremely low birth weight and controls at adolescence. Pediatrics.\u20082001;108(2):407\u2013415","DOI":"10.1542\/peds.108.2.407"},{"key":"2021120820163982700_R109","doi-asserted-by":"crossref","unstructured":"Ferrara TB, Hoekstra RE, Couser RJ, Burrows E. Survival and follow-up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapy. J Pediatr.\u20081994;124(1):119\u2013124","DOI":"10.1016\/S0022-3476(94)70266-7"},{"key":"2021120820163982700_R110","doi-asserted-by":"crossref","unstructured":"Sinn JK, Ward MC, Henderson-Smart DJ. Developmental outcome of preterm infants after surfactant therapy: systematic review of randomized controlled trials. J Paediatr Child Health.\u20082002;38(6):597\u2013600","DOI":"10.1046\/j.1440-1754.2002.00061.x"},{"key":"2021120820163982700_R111","doi-asserted-by":"crossref","unstructured":"Sinkin RA, Kramer BM, Merzback JL, et al. School-age follow-up of a prophylactic versus rescue surfactant trial: pulmonary, neurodevelopmental, and educational outcomes. Pediatrics.\u20081998;101(5). Available at: www.pediatrics.org\/cgi\/content\/full\/101\/5\/e11","DOI":"10.1542\/peds.101.5.e11"},{"key":"2021120820163982700_R112","doi-asserted-by":"crossref","unstructured":"Saigal S, Pinelli J, Hoult L, Kim MM, Boyle M. Psychopathology and social competencies of adolescents who were extremely low birth weight. Pediatrics.\u20082003;111(5 pt 1):969\u2013975","DOI":"10.1542\/peds.111.5.969"},{"key":"2021120820163982700_R113","doi-asserted-by":"crossref","unstructured":"Jobe AH, Mitchell BR, Gunkel JH. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol.\u20081993;168(2):508\u2013513","DOI":"10.1016\/0002-9378(93)90483-Y"},{"key":"2021120820163982700_R114","unstructured":"Kari MA, Hallman M, Eronen M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics.\u20081994;93(5):730\u2013736"},{"key":"2021120820163982700_R115","unstructured":"Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev.\u20082000;(2):CD000065"},{"key":"2021120820163982700_R116","unstructured":"National Institutes of Health. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement.\u20081994;12(2):1\u201324"},{"key":"2021120820163982700_R117","doi-asserted-by":"crossref","unstructured":"Wright LL, Horbar JD, Gunkel H, et al. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants. Am J Obstet Gynecol.\u20081995;173(1):263\u2013269","DOI":"10.1016\/0002-9378(95)90211-2"},{"key":"2021120820163982700_R118","doi-asserted-by":"crossref","unstructured":"Chien LY, Ohlsson A, Seshia MM, et al. Variations in antenatal corticosteroid therapy: a persistent problem despite 30 years of evidence. Obstet Gynecol.\u20082002;99(3):401\u2013408","DOI":"10.1016\/S0029-7844(01)01732-X"},{"key":"2021120820163982700_R119","doi-asserted-by":"crossref","unstructured":"Papageorgiou AN, Desgranges MF, Masson M, Colle E, Shatz R, Gelfand MM. The antenatal use of betamethasone in the prevention of respiratory distress syndrome: a controlled double-blind study. Pediatrics.\u20081979;63(1):73\u201379","DOI":"10.1542\/peds.63.1.73"},{"key":"2021120820163982700_R120","doi-asserted-by":"crossref","unstructured":"Silver RK, Vyskocil C, Solomon SL, Ragin A, Neerhof MG, Farrell EE. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks gestation. Obstet Gynecol.\u20081996;87(5 pt 1):683\u2013691","DOI":"10.1016\/0029-7844(96)00033-6"},{"key":"2021120820163982700_R121","doi-asserted-by":"crossref","unstructured":"White A, Marcucci G, Andrews E, Edwards K, Long W. Antenatal steroids and neonatal outcomes in controlled clinical trials of surfactant replacement. Am J Obstet Gynecol.\u20081995;173(1):286\u2013290","DOI":"10.1016\/0002-9378(95)90215-5"},{"key":"2021120820163982700_R122","doi-asserted-by":"crossref","unstructured":"Garite TJ, Rumney PJ, Briggs GG, et al. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol.\u20081992;166(2):646\u2013651","DOI":"10.1016\/0002-9378(92)91691-3"},{"key":"2021120820163982700_R123","doi-asserted-by":"crossref","unstructured":"Wright LL, Verter J, Younces N, et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: the NICHD Neonatal Research Network. Am J Obstet Gynecol.\u20081995;173(1):269\u2013274","DOI":"10.1016\/0002-9378(95)90212-0"},{"key":"2021120820163982700_R124","doi-asserted-by":"crossref","unstructured":"Van Marter LJ, Allred EN, Leviton A, Pagano M, Parad R, Moore M. Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr.\u20082001;138(2):198\u2013204","DOI":"10.1067\/mpd.2001.110980"},{"key":"2021120820163982700_R125","doi-asserted-by":"crossref","unstructured":"Seidner S, Pettenazzo A, Ikegami M, Jobe A. Corticosteroid potentiation of surfactant dose response in preterm rabbits. J Appl Physiol.\u20081988;64(6):2366\u20132371","DOI":"10.1152\/jappl.1988.64.6.2366"},{"key":"2021120820163982700_R126","doi-asserted-by":"crossref","unstructured":"Ikegami M, Jobe AH, Seidner S, Yamada T. Gestational effects of corticosteroids and surfactant in ventilated rabbits. Pediatr Res.\u20081989;25(1):32\u201337","DOI":"10.1203\/00006450-198901000-00007"},{"key":"2021120820163982700_R127","doi-asserted-by":"crossref","unstructured":"Gladstone IM, Mercurio MR, Devenny SG, Jacobs HC. Antenatal steroids, postnatal surfactant, and pulmonary function in premature rabbits. J Appl Physiol.\u20081989;67(4):1377\u20131382","DOI":"10.1152\/jappl.1989.67.4.1377"},{"key":"2021120820163982700_R128","doi-asserted-by":"crossref","unstructured":"Ho JJ, Subramaniam P, Henderson-Smart DJ, Davis PG. Continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev.\u20082002;(2):CD002271","DOI":"10.1002\/14651858.CD002271"},{"key":"2021120820163982700_R129","doi-asserted-by":"crossref","unstructured":"Gittermann MK, Fusch C, Gittermann AR, Regazzoni BM, Moessinger AC. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infants. Eur J Pediatr.\u20081997;156(5):384\u2013388","DOI":"10.1007\/s004310050620"},{"key":"2021120820163982700_R130","doi-asserted-by":"crossref","unstructured":"Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med.\u20081994;331(16):1051\u20131055","DOI":"10.1056\/NEJM199410203311603"},{"key":"2021120820163982700_R131","doi-asserted-by":"crossref","unstructured":"Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics.\u20081999;103(2). Available at: www.pediatrics.org\/cgi\/content\/full\/103\/2\/e24","DOI":"10.1542\/peds.103.2.e24"},{"key":"2021120820163982700_R132","doi-asserted-by":"crossref","unstructured":"Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants &lt;30 weeks' gestation. Pediatrics.\u20082004;113(6). Available at: www.pediatrics.org\/cgi\/content\/full\/113\/6\/e560","DOI":"10.1542\/peds.113.6.e560"},{"key":"2021120820163982700_R133","doi-asserted-by":"crossref","unstructured":"Kamper J, Feilberg Jorgensen N, Jonsbo F, Pedersen-Bjergaard L, Pryds O. The Danish national study in infants with extremely low gestational age and birth weight (the ETFOL study): respiratory morbidity and outcome. Danish ETFOL Study Group. Acta Paediatr.\u20082004;93(2):225\u2013232","DOI":"10.1111\/j.1651-2227.2004.tb00711.x"},{"key":"2021120820163982700_R134","doi-asserted-by":"crossref","unstructured":"Meyer M, Mildenhall L, Wong M. Outcomes for infants weighing less than 1000 grams cared for with a nasal continuous positive airway pressure-based strategy. J Paediatr Child Health.\u20082004;40(1\u20132):38\u201341","DOI":"10.1111\/j.1440-1754.2004.00287.x"},{"key":"2021120820163982700_R135","doi-asserted-by":"crossref","unstructured":"De Klerk AM, De Klerk RK. Nasal continuous positive airway pressure and outcomes of preterm infants. J Paediatr Child Health.\u20082001;37(2):161\u2013167","DOI":"10.1046\/j.1440-1754.2001.00624.x"},{"key":"2021120820163982700_R136","doi-asserted-by":"crossref","unstructured":"Jo\u0301nsson B, Katz-Salamon M, Faxelius G, Broberger U, Lagercrantz H. Neonatal care of very-low-birth weight infants in special-care units and neonatal intensive-care units in Stockholm: early nasal continuous positive airway pressure versus mechanical ventilation\u2014gains and losses. Acta Paediatr Suppl.\u20081997;419:4\u201310","DOI":"10.1111\/j.1651-2227.1997.tb18303.x"},{"key":"2021120820163982700_R137","unstructured":"Wung JT. Continuous positive airway pressure. In: Wung JT, Polin RA, eds. Respiratory Care of the Newborn: A Practical Approach. New York, NY: Babies and Children's Hospital; 2000"},{"key":"2021120820163982700_R138","doi-asserted-by":"crossref","unstructured":"Finer NN, Carlo WA, Duara S, et al. Delivery room continuous positive airway pressure\/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. NICHD Neonatal Research Network. Pediatrics.\u20082004;114(3):651\u2013657","DOI":"10.1542\/peds.2004-0394"},{"key":"2021120820163982700_R139","doi-asserted-by":"crossref","unstructured":"Lindner W, Vosseck S, Hummler H, Pohlandt F. Delivery room management of extremely low birth weight infants: spontaneous breathing or intubation?Pediatrics.\u20081999;103(5 pt 1):961\u2013967","DOI":"10.1542\/peds.103.5.961"},{"key":"2021120820163982700_R140","doi-asserted-by":"crossref","unstructured":"Sandri F, Ancora G, Lanzoni A. et al. Prophylactic nasal continuous positive airways pressure in newborns 28\u201331 weeks gestation: multicenter randomized controlled clinical trial. Arch Dis Child Fetal Neonatal Ed.\u20082004;89(5):F394\u2013F398","DOI":"10.1136\/adc.2003.037010"},{"key":"2021120820163982700_R141","doi-asserted-by":"crossref","unstructured":"Aly H, Milner JD, Patel K, El-Mohandes AA. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants?Pediatrics.\u20082004;114(3):697\u2013702","DOI":"10.1542\/peds.2003-0572-L"},{"key":"2021120820163982700_R142","unstructured":"Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Cochrane Database Syst Rev.\u20082000;(2):CD003063"},{"key":"2021120820163982700_R143","doi-asserted-by":"crossref","unstructured":"Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics.\u20081987;79(1):26\u201330","DOI":"10.1542\/peds.79.1.26"},{"key":"2021120820163982700_R144","doi-asserted-by":"crossref","unstructured":"Van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatal Committee for the Developmental Network. Pediatrics.\u20082000;105(6):1194\u20131201","DOI":"10.1542\/peds.105.6.1194"},{"key":"2021120820163982700_R145","unstructured":"Alpan G, Clyman RI. Cardiovascular effects of surfactant replacement with special reference to the patent ductus arteriosus. In: Robertson B, Taeusch HW, eds. Lung Biology in Health and Disease: Surfactant Therapy for Lung Disease. New York, NY: Marcel Dekker; 1995:531\u2013545"},{"key":"2021120820163982700_R146","doi-asserted-by":"crossref","unstructured":"Clyman RI. Patent ductus arteriosus in the premature infant. In: Taeusch HW, Ballard RA, Gleason CA, eds. Avery's Diseases of the Newborn. 8th ed. Philadelphia, PA: Elsevier Saunders; 2005:816\u2013826","DOI":"10.1016\/B978-072169347-7.50058-5"},{"key":"2021120820163982700_R147","doi-asserted-by":"crossref","unstructured":"Taeusch HW, Ramierez-Schrempp D, Laing IA. Surfactant treatment of respiratory disorders. In: Taeusch HW, Ballard RA, Gleason CA, eds. Avery's Disease of the Newborn. 8th ed. Philadelphia, PA: Elsevier Saunders; 2005:670\u2013685","DOI":"10.1016\/B978-072169347-7.50048-2"},{"key":"2021120820163982700_R148","doi-asserted-by":"crossref","unstructured":"Couser RJ, Ferrera BT, Wright GB, et al. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. J Pediatr.\u20081996;128(5 pt 1):631\u2013637","DOI":"10.1016\/S0022-3476(96)80127-2"},{"key":"2021120820163982700_R149","doi-asserted-by":"crossref","unstructured":"Raju TN, Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. J Pediatr.\u20081993;123(4):603\u2013610","DOI":"10.1016\/S0022-3476(05)80963-1"},{"key":"2021120820163982700_R150","doi-asserted-by":"crossref","unstructured":"Valls-i-Soler A, Lopez-Heredia J, Fernandez-Ruanova MD, Gastiasoro E. A simplified surfactant dosing procedure in respiratory distress syndrome: the \u201cside-hole\u201d randomized study. Spanish Surfactant Collaborative Group. Acta Paediatr.\u20081997;86(7):747\u2013751","DOI":"10.1111\/j.1651-2227.1997.tb08579.x"},{"key":"2021120820163982700_R151","doi-asserted-by":"crossref","unstructured":"Stark AR; American Academy of Pediatrics, Committee on Fetus and Newborn. Levels of neonatal care [published correction appears in Pediatrics. 2005;115:1118]. Pediatrics.\u20082004;114(5):1341\u20131347","DOI":"10.1542\/peds.2004-1697"},{"key":"2021120820163982700_R152","doi-asserted-by":"crossref","unstructured":"Contributors and Reviewers for the Neonatal Resuscitation Guidelines. International guidelines for neonatal resuscitation: an excerpt from the guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: international consensus on science. Pediatrics. 2000;106(3):e29. Available at: www.pediatrics.org\/cgi\/content\/full\/106\/3\/e29. Accessed December 20, 2007","DOI":"10.1542\/peds.106.3.e29"},{"key":"2021120820163982700_R153","doi-asserted-by":"crossref","unstructured":"Warner B, Musial MJ, Chenier T, Donovan E. The effect of birth hospital type on the outcome of very low birth weight infants. Pediatrics.\u20082004;113(1 pt 1):35\u201341","DOI":"10.1542\/peds.113.1.35"},{"key":"2021120820163982700_R154","doi-asserted-by":"crossref","unstructured":"Chin SO, Brodsky NL, Bhandari V. Antenatal steroid use is associated with increased gastroesophageal reflux in neonates. Am J Perinatol.\u20082003;20(4):205\u2013213","DOI":"10.1055\/s-2003-40605"},{"key":"2021120820163982700_R155","doi-asserted-by":"crossref","unstructured":"Lee SK, McMillan DD, Ohlsson A, et al. Variations in practice and outcomes in the Canadian NICU Network: 1996\u20131997. Pediatrics.\u20082000;106(5):1070\u20131079","DOI":"10.1542\/peds.106.5.1070"},{"key":"2021120820163982700_R156","unstructured":"The Cochrane Collaboration. Available at: www.cochrane.org\/resources\/revpro.htm. Accessed May 3, 2007"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/2\/419\/1122078\/zpe00208000419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/2\/419\/1122078\/zpe00208000419.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:31:17Z","timestamp":1684218677000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/2\/419\/68699\/Surfactant-Replacement-Therapy-for-Respiratory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,1]]},"references-count":156,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,2,1]]},"published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-3283","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,1]]}}}